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T Cell Studies in a Peptide-Induced Model of Systemic Lupus
Erythematosus
Magi Khalil,* Kayo Inaba,‡ Ralph Steinman,‡ Jeffrey Ravetch,‡ and Betty Diamond1†

M

any studies have shown that both B and T cells play a
central role in autoimmune disease. The serum response in systemic lupus erythematosus (SLE)2 contains autoreactivities to a variety of nuclear Ags, of which antidsDNA reactivity is the most important prognostic factor (1). In
murine lupus models, disruption of T cell activation (2– 8) or an
absence of T cells (9, 10) abrogates autoantibody production and
glomerulonephritis. In addition, nephritogenic anti-dsDNA Abs
are high affinity, somatically mutated IgG Abs, all of which are
features of a T cell-dependent, Ag-driven immune response (11,
12). Sequence analyses of anti-dsDNA Abs, showing a greater
than random ratio of replacement to silent mutations in complementarity-determining regions, suggests that DNA could be the
selecting Ag for these Abs (13–15). Since uncomplexed mammalian DNA is poorly immunogenic (16), and T cells are unlikely to
recognize dsDNA in the context of MHC, models have emerged in
which DNA-associated proteins or anti-dsDNA Abs themselves
provide the T cell epitope that drives anti-dsDNA production.
In an attempt to identify other potential antigenic stimuli that
could induce anti-dsDNA Abs, we used a high affinity mouse
monoclonal IgG2b pathogenic anti-dsDNA Ab, R4A, to screen a
phage decapeptide display library. Sequence alignment of the
selected peptides revealed a five-amino acid consensus sequence
(DWEYS) (17). Immunization with a multimeric form of a
decapeptide containing this five-amino acid sequence
(DWEYSVWLSN-MAP) led to an SLE-like syndrome in BALB/c
mice (18). To understand the basis for the loss of self-tolerance in

BALB/c mice following immunization and to determine the validity of this system as a model for SLE, we have examined the
role of T cells in the anti-foreign and anti-self response.

Materials and Methods
Mice
Eight- to 10-wk-old female wild-type and nude BALB/c mice were purchased from The Jackson Laboratory (Bar Harbor, ME). Mice were housed
in the Albert Einstein College of Medicine (Bronx, NY) animal (specific
pathogen-free) barrier facility or in the barrier facility of Rockefeller University (New York, NY).

Antigens
The peptides, DWEYSVWLSN, DWEYSVWLSN-MAP, DWEYSVWLSMAP, DWEYSVWL-MAP, DWEYSVW-MAP, DWEYSV-MAP,
DWEYS-MAP, VWLSN-MAP, DWEYSVWLSN-MAP (4), DWEYSAA
AAA-MAP, (DWEYSVWLSN)3, DWEYSEGL-MAP, (DWEYSEGL)3,
DWSSDVWLSN-MAP, and DWEYSVWLSM-MAP used in immunizations and T cell proliferation assays were purchased from Research Genetics (Huntsville, AL), and their purities and/or sequences were verified
by either HPLC or amino acid analysis. Unless otherwise indicated, all
MAP peptides are linked to an eight-branch polylysine backbone. Peptides
soluble at neutral pH were dissolved in dH2O, whereas those insoluble at
neutral pH were dissolved in dH2O with pH adjusted to 8.5 to produce 10
mg/ml stock solutions. MAP backbone (Anaspec, San Jose, CA), histones
(Sigma, St. Louis, MO), and Smith Ag/ribonuclear proteins (Sm/RNPs)
(Immunovision, Springdale, AR) were dissolved in dH2O to produce 10
mg/ml stock solutions.

Immunizations for serum studies
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Mice were immunized s.c. with 100 g of DWEYSVWLSN-MAP,
DWEYSVWLSN, (DWEYSVWLSN)3, (DWEYSEGL)3, or DWEYSMAP in 200 l of PBS/CFA H37 Ra (1/1; Difco, Detroit, MI) on day 0 and
then boosted in IFA (Difco) on days 7 and 14. Control mice received either
100 g of MAP backbone (MAP core) in adjuvant or adjuvant alone using
the same protocol. Serum was obtained on days 0, 7, 14, 21, 35, and 49.
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Enzyme immunoassay/RIA high binding 96-well plates (Costar, Corning,
NY) were coated with 30 l of 15 g/ml of the relevant peptide and
incubated overnight at 4°C. Plates were blocked with 100 l of 3% FCS
(HyClone, Logan, UT) in PBS at 37°C for 1 h, then washed with PBS0.05% Tween. Thirty microliters of diluted sera were added to the plates
for 2 h at 37°C. Plates were then washed with PBS-Tween, and 30 l of
alkaline phosphatase-conjugated goat anti-mouse IgG or IgG1 (Southern
Biotechnology Associates, Birmingham, AL) diluted 1/1000 in 3% FCS/
0022-1767/01/$02.00
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We have previously reported that immunization with a peptide mimetope of dsDNA on a branched polylysine backbone
(DWEYSVWLSN-MAP) induces a systemic lupus erythematosus-like syndrome in the nonautoimmune BALB/c mouse strain. To
understand the mechanism underlying this breakdown in self tolerance, we examined the role of T cells in the response. Our results
show that the anti-foreign and anti-self response induced by immunization is T cell dependent and is mediated by I-Ed-restricted
CD4ⴙ T cells of the Th1 subset. In addition, generation of the critical T cell epitope requires processing by APCs and depends on
the presence of both DWEYSVWLSN and the MAP backbone. The breakdown in self tolerance does not occur through crossreactivity between the T cell epitope of DWEYSVWLSN-MAP and epitopes derived from nuclear Ags. In this induced-model of
SLE, therefore, autoreactivity results from the activation of T cells specific for foreign Ag and of cross-reactive anti-foreign,
anti-self B cells. Despite the fact that tissue injury is mediated by Ab, the critical initiating T cell response is Th1. The Journal
of Immunology, 2001, 166: 1667–1674.
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(Woburn, MA). Cytokine concentrations were determined based on standard curves.

Double-stranded DNA ELISA

Determination of peptide processing and responding T cells

Calf-thymus DNA (Calbiochem-Novabiochem, La Jolla, CA) was dissolved in PBS, sonicated, and filtered through a 0.45-m nitrocellulose
Millex syringe filter (Millipore, Bedford, MA) to produce dsDNA in 10- to
20-kbp fragments. Thirty microliters of 100 g/ml dsDNA was used to
coat enzyme immunoassay/RIA high binding 96-well plates (Costar) overnight at 37°C. The remainder of the assay was performed as described for
the peptide ELISA.

The basic protocol for DC-induced T cell proliferation was as follows. T
cells were purified from lymph nodes of wild-type BALB/c mice that were
immunized in their footpads with DWEYSVWLSN-MAP in CFA or CFA
alone 1 wk earlier as described above. These purified T cells (1–3 ⫻ 105)
were then cocultured in triplicate for 72 h with 0.1–1 ⫻ 105 DC that were
purified, pulsed, and irradiated as described above. T cell proliferation was
assayed as described above. To determine which population of T cells
proliferates in response to DWEYSVWLSN-MAP, CD4 and CD8 T cells
were each purified and used separately in these assays. To determine
whether DWEYSVWLSN-MAP requires uptake for presentation to cognate T cells, DC were pulsed with various concentrations of MAP peptide
at 4 or 37°C for 3 h on day 6 of culture, washed twice, and plated at 6 ⫻
105 cells/ml in GM-CSF medium in the presence of 0.5 ng/ml of LPS. To
safeguard against nonspecific effects of the lower temperature on the Agpresenting capabilities of DC, control DC were placed at 4°C for 3 h before
receiving Ag and LPS during overnight culture. On day 7, DC were
washed, irradiated, and cocultured with T cells purified from lymph nodes
of wild-type BALB/c mice as described above. T cell proliferation was
then assayed as described. To determine whether DWEYSVWLSN-MAP
requires processing for presentation to cognate T cells, DC were pulsed
with various concentrations of peptide and LPS as described above in the
presence or the absence of 20 mM NH4Cl on day 6 of culture. On day 7,
DC were washed twice in RPMI, then fixed with 4% paraformaldehyde in
PBS for 30 min at 4°C. Control DC were either not fixed following NH4Cl
treatment or were fixed before overnight Ag pulsing. DC were washed,
irradiated, and cocultured with T cells purified from lymph nodes of wildtype BALB/c mice as described above. T cell proliferation was then assayed as described.

T cell purification
Wild-type BALB/c mice were immunized in the right front and hind footpads with 100 g of DWEYSVWLSN-MAP in 100 l of PBS/CFA H37
Ra (1/1) and in the left front and hind footpads with 100 l of PBS:/FA
H37 Ra (1/1) alone (50 l was administered per footpad). One week later,
cells from the left and right popliteal, axillary, and brachial lymph nodes
were harvested separately in RPMI 1640 medium (Life Technologies,
Grand Island, NY) supplemented with 5% FCS, 100 U/ml penicillin, 100
g/ml streptomycin, and 50 M ␤-ME. Following RBC lysis, cells at 2 ⫻
107 cells/ml were incubated at 4°C for 30 min with supernatants from the
following American Type Culture Collection cell lines (Manassas, VA):
TIB-120 (anti-I-Ab,d,q and anti I-Ed,k), HB-198 (anti-mouse macrophage),
RA3-6B2.1 (anti-B220), and either TIB-207 (anti-CD4) or TIB-105 (antiCD8). Excess Ab was washed away, and the cells were incubated with
sheep anti-rat IgG Dynabeads (Dynal, Oslo, Norway) in a 1/4 ratio, respectively, at 4°C for 30 min with rotation. CD4 or CD8 T cells (⬎96%
purity as determined by FACS) were isolated by magnetic bead depletion
(Dynal).

Preparation and Ag pulsing of dendritic cells (DC)
Bone marrow-derived DC were grown as previously described (19).
Briefly, bone marrow was harvested from the femur and tibia of wild-type
BALB/c mice on day 0. RBC lysis was achieved using ammonium chloride, and the resulting cells were depleted of T cells, B cells, and APCs by
resuspension at 1 ⫻ 107 cells/ml in supernatants from the American Type
Culture Collection cell lines TIB-120 (anti-I-Ab,d,q and anti I-Ed,k), TIB211 (anti-CD8), TIB-207 (anti-CD4), and TIB-146 (anti-B220) in the presence of rabbit complement (Pel-Freeze Biologicals, Rogers, AR) for 1 h at
37°C. The resulting cells were washed and placed in 24-well plates at 1 ⫻
106 cells/ml in RPMI 1640 medium supplemented with 5% FCS, 2 mM
glutamine, 100 U/ml penicillin, 100 g/ml streptomycin, and GM-CSF
containing supernatants from J558L cells (diluted 1/30). Cells were fed
with fresh medium on days 2 and 4. On day 6 the nonadherent cells were
collected and plated at 5 ⫻ 105 cells/ml in GM-CSF-containing medium in
the presence of 0.5 ng/ml LPS (Sigma) and various concentrations of
DWEYSVWLSN-MAP. The Ag-pulsed DC were collected on day 7,
washed twice in RPMI, irradiated with 1500 rad (137Cs), and resuspended
in Click’s medium (Irvine Scientific, Santa Ana, CA) supplemented with
0.75% heat-inactivated normal mouse serum, 2 mM glutamine, 100 U/ml
penicillin, 100 g/ml streptomycin, and 50 M 2-ME.

Lymph node T cell proliferation assays
Mice were immunized in the right fore and hind footpads with 100 g of
DWEYSVWLSN-MAP in 100 l of PBS:CFA H37 Ra (1/1) and in the left
fore and hind footpads with 100 l of PBS:CFA H37 Ra (1/1) alone (50
l/footpad). One week later, cells from the left and right popliteal, axillary,
and brachial lymph nodes were harvested separately and plated at 3 ⫻ 105
cells/well in 96-well flat-bottom plates in Click’s medium supplemented
with 0.75% normal mouse serum (Taconic Farms, Germantown, NY), 8
mM L-glutamine, 100 U/ml penicillin, 100 g/ml streptomycin, and 50 M
␤-ME. Cells were pulsed with several concentrations of the various peptides or purified protein derivative (Statens Serum Institute Copenhagen,
Denmark) in triplicate for 72 h. Each well was pulsed with 0.5 Ci of
[3H]thymidine (sp. act., 20 Ci/mmol) for 8 h. Cells were harvested, and the
incorporated radioactivity was counted using a Wallac Tomtec harvester 96
Mach III M and a 1450 liquid scintillation Microbeta counter (Turku,
Finland).

Cytokine ELISAs
Lymph node T cell proliferation assays were performed as described
above. After 72 h supernatants from each well were tested for the presence
of IL-2, IL-4, and IFN-␥ using the Endogen mouse cytokine ELISA kits

MHC restriction of in vivo primed T cells
To determine the MHC haplotype responsible for presenting
DWEYSVWLSN-MAP, lymph node T cell proliferation assays were conducted as described above in the presence of 50 g/ml of
DWEYSVWLSN-MAP and blocking Abs to I-Ad and I-Ed. These Abs
were purified from ascites produced by the inoculation of SCID mice with
the cell lines MKD6 (American Type Culture Collection HB-3) and 1444S
(American Type Culture Collection HB-32), which secrete IgG2a antimouse I-Ad and anti-mouse I-Ed Abs, respectively. The purities of the Igs
were verified by SDS-PAGE, and their concentrations were measured by
both absorbance at 280 nm and quantitative ELISA using an IgG2a standard (20).

Statistics
Comparisons between two groups were performed using Student’s t test.
Error bars represent SEM values. p ⬍ 0.05 was considered statistically
significant. Unless otherwise indicated, p values represent comparisons
made on day 49 at the highest dose of antigenic pulse or at the highest
concentration of blocking Ab.

Results
The anti-foreign and anti-self response is T cell dependent
The autospecificities that are correlated with disease manifestations of SLE, specifically anti-dsDNA Abs, are high affinity, IgG,
somatically mutated Abs produced by B cells in a T cell-dependent
fashion (11, 12). Peptide-induced SLE is characterized by antipeptide, anti-DNA cross-reactive Abs that also display somatic
mutation (18, 21). To determine whether the anti-foreign and antiself response exhibited in peptide-induced SLE reproduces the T
cell dependence of spontaneous SLE, nude and wild-type BALB/c
mice were immunized with DWEYSVWLSN-MAP. Fig. 1 indicates that athymic nude mice do not mount an Ab response against
either the peptide or dsDNA, affirming that the mechanism underlying induction of autoimmunity following peptide immunization
is T cell dependent.
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PBS was added to the plates for 1 h at 37°C, followed by 30 l of pnitrophenyl phosphate solution (Sigma). OD was monitored at 405 nm
using a Titer-Tek Multiscan ELISA reader (Titertek, Huntsville, AL).

The Journal of Immunology

The anti-peptide response is mediated by CD4 I-Ed-restricted
Th1 T cells
To determine which T cell population was responsible for the antipeptide response, CD4 and CD8 T cells were purified from the
lymph nodes of mice immunized with DWEYSVWLSN-MAP.
Fig. 2A shows that proliferation to peptide-pulsed DC was detectable only in the CD4 population, indicating that the peptide response is mediated by CD4 T cells. This is further supported by the
observation that culturing lymph node cells from immunized mice
with peptide results in the selective proliferation of CD4 and the
death of CD8 cells. The ratio of CD4/CD8 increases from 1.7 to
5.0 during in vitro culture of primed lymph node cells with peptide
( p ⫽ 0.002; data not shown).
It has been previously speculated that T cells that drive the propagation of anti-dsDNA-producing B cells are more likely to be
I-Ed restricted because the preponderance of negative charges in
the binding pocket of these class II molecules allows the binding
of peptides derived from positively charged DNA-associated proteins (22). To determine the MHC restriction of the anti-peptide T
cells, mice were immunized with either DWEYSVWLSN-MAP in
CFA or CFA alone. Cells from the draining lymph nodes were
harvested 1 wk later and pulsed with DWEYSVWLSN-MAP in
the presence of various concentrations of Ab to either I-Ed or I-Ad.
Fig. 2B shows that only Ab to I-Ed was able to block T cell proliferation in response to the peptide from maximal to background

FIGURE 2. T cell restriction of DWEYSVWLSN-MAP. A, CD4 restriction. CD4 and CD8 T cells were purified from the lymph nodes of
BALB/c mice immunized 1 wk earlier with DWEYSVWLSN-MAP. Part
(1 ⫻ 105) of each T cell population was incubated in triplicate with 1 ⫻ 104
DC that had been pulsed with varying doses of peptide, washed, and irradiated as described in Materials and Methods. T cell proliferation was
assayed as a function of incorporated radioactivity. Results are presented as
the mean counts per minute for triplicate determinations of T cells and DC
cultures and show dose-dependent CD4 T cell proliferation and no CD8 T
cell proliferation in response to peptide (p ⫽ 0.0004). B, I-Ed restriction.
Five mice were immunized with either CFA or CFA and
DWEYSVWLSN-MAP. One week later their lymph node cells were harvested and plated in triplicate with 50 g/ml of DWEYSVWLSN-MAP in
the presence of increasing concentration of blocking Abs to I-Ed or I-Ad as
described in Materials and Methods. The data show inhibition by anti-I-Ed
Ab (p ⫽ 5 ⫻ 10⫺12) and are expressed as the mean counts per minute of
five mice, each determined in triplicate.

in a dose-dependent manner. Ab to I-Ad had no effect and served
as an isotype-matched control for the I-Ed Ab.
Both the Th1 and Th2 T cell-derived cytokines have been implicated in mediating disease in SLE. To determine which cytokines are produced when T cells are activated in response to peptide immunization, we assayed for cytokine production in lymph
node cells 1 wk following peptide immunization. As is apparent
from Fig. 3, BALB/c mice up-regulate IL-2 and IFN-␥ following
peptide immunization, while IL-4 levels are unchanged, indicating
that Th1 cells are the peptide-responsive T cells at the onset of the
immune response.
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FIGURE 1. T cell dependence of anti-DWEYSVWLSN-MAP and antidsDNA response. Wild-type and nude BALB/c mice were immunized with
DWEYSVWLSN-MAP in CFA on day 0 and then boosted in IFA on days
7 and 14. IgG anti-peptide (A) and IgG1 anti-dsDNA (B) reactivities assayed by ELISA in 1/500 diluted sera show that wild-type mice have significantly greater serum responses to peptide (p ⫽ 4 ⫻ 10⫺13) and to
dsDNA (p ⫽ 0.009) than nude mice. Results are expressed as the mean
absorbance at 405 nm of eight nude and five wild-type mice, each determined in duplicate, and are representative of two separate experiments each
containing five to eight nude and wild-type mice.
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FIGURE 4. T cell proliferation of DWEYSVWLSN-MAP-immunized
mice in response to various peptides. BALB/c mice were immunized with the
eight-branched MAP peptide (DWEYSVWLSN-MAP) in CFA or with CFA
alone. One week later their lymph node cells were pulsed in vitro with equimolar amounts of the original immunizing peptide or a panel of peptides with the
sequences shown (A–C). Compared with the CFA control, which is not
graphed, p values for proliferation in response to each peptide in a from left to
right are 2.1 ⫻ 10⫺9, 1.3 ⫻ 10⫺6, 2.8 ⫻ 10⫺6, 0.001, 0.002, 0.1, 0.2, and 0.4.
The results are shown as the average counts per minute of five individual mice,
each assayed in triplicate.

Both the peptide as well as the MAP backbone contribute to the
T cell epitope in the anti-foreign and anti-self response
To understand how the MAP peptide-reactive T cells lead to subsequent autoimmunity, we sought to define the T cell epitope.
Therefore, BALB/c mice were immunized with DWEYSVWLSNMAP in CFA or CFA alone. One week later cells from the draining
lymph nodes were harvested and pulsed in vitro with purified protein derivative, the immunizing peptide, or a panel of related peptides. T cell proliferation was assayed as a function of incorporated
radioactivity. Fig. 4A shows that the immunizing peptide as well as
the peptide lacking the asparagine at residue 10 were able to elicit
comparable T cell proliferation, indicating that residue 10 is not a
necessary component of the T cell epitope. Proliferation decreased
with successively shorter peptides until the DWEYSV-MAP,
where proliferation was no longer detectable. T cell proliferation
also seems to require the presence of the MAP backbone, since

monomeric peptides (DWEYSVWLSN and (DWEYSVWLSN)3)
induced no proliferation, and peptide linked to the four-branch
MAP backbone showed less than maximal proliferation (Fig. 4, A
and B). It is the actual sequence of the peptide and not its valency
that is important, because peptides that had a nonconservative
amino acid substitution from asparagine to methionine in the last
position or that had alterations in the consensus sequence DWEYS
(DWSSDVWLSN-MAP) or in the last five amino acids of the
peptide (DWEYS-MAP, DWEYSAAAAA-MAP, and DWEY
SEGL-MAP) did not induce T cell proliferation (Fig. 4, B and C).
The results from these T cell studies confirmed the serologic data
shown in Fig. 5 demonstrating that neither DWEYS-MAP, the
monomeric peptide DWEYSVWLSN, nor the tandem repeat
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FIGURE 3. DWEYSVWLSN-MAP induces Th1 T cells. Cytokine
ELISAs to assay for the production of IL-2 (A), IFN-␥ (B), and IL-4 (C) by
lymph node cells of mice immunized with either CFA or CFA and
DWEYSVWLSN-MAP as described in Materials and Methods. Data are
expressed as the mean cytokine concentration produced by proliferating T
cells from five mice, each determined in triplicate. IL-2 (p ⫽ 0.006) and
IFN-␥ (p ⫽ 0.0007) production is peptide specific. IL-4 levels are not
up-regulated by peptide pulsing. The results are representative of four separate experiments containing five mice in each group with similar results.

The Journal of Immunology
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(DWEYSVWLSN)3 could induce a serum response to the immunizing peptides, presumably because of their inability to generate
a T cell epitope.
DWEYSEGL is another consensus (DWEYS)-containing peptide that was selected from the phage library (17). Interestingly,
while immunization with a tandem repeat of this peptide was able
to induce both T cell proliferation ( p ⫽ 0.008; data not shown) and
a serum response to the peptide (Fig. 6A), no anti-dsDNA response
was detectable above background (Fig. 6B). In addition, the anti(DWEYSEGL)3 Abs generated did not cross-react with DWEYS
VWLSN-MAP (Fig. 6C), DWEYS-MAP, or DWEYSVWLSN
(data not shown), nor was there a common T cell epitope between
(DWEYSEGL)3 and DWEYSVWLSN-MAP (Fig. 4B). Taken together these results suggest that generation of the critical T cell
epitope requires both the peptide and the MAP backbone and indicate the importance of the nonconsensus amino acids as well as
the MAP backbone in generating the anti-dsDNA response and the
anti-foreign response.
DWEYSVWLSN-MAP requires processing for presentation to
T cells
We wanted to determine whether the MAP peptide had to be processed for presentation to cognate T cells. To this end, we tested
whether NH4Cl, which inhibits acidification and proteolysis within
endocytic vacuoles (23), could block T cell proliferation to the
peptide. Fig. 7A shows that DC pulsed with Ag in the presence of
20 mM NH4Cl and then fixed were significantly less capable of
inducing T cell proliferation than DC pulsed with Ag and then
fixed ( p ⫽ 0.001). In addition, DC fixed before Ag pulse were
completely unable to induce T cell proliferation (data not shown).
The results of these studies are further confirmed by experiments
showing that DCs pulsed with Ag at 4°C, which prevents Ag internalization, were much less effective at inducing T cell prolifer-

FIGURE 6. Serum reactivity following (DWEYSEGL)3 immunization.
Mice were immunized with (DWEYSEGL)3 in CFA on day 0 and then
boosted with IFA on days 7 and 14. Control mice were immunized with
adjuvant alone using the same regimen. IgG anti-(DWEYSEGL)3 (A), antidsDNA (B), and anti-DWEYSVWLSN-MAP (C) reactivities were assayed
by ELISA in 1/500 diluted sera. Results are expressed as the mean absorbance at 405 nm of five mice in each group. All assays were performed in
duplicate.

ation than those pulsed at 37°C ( p ⫽ 0.03; Fig. 7B). Overall, these
results indicate that the peptide requires internalization and processing by APCs for the generation of a T cell epitope and subsequent proliferation.
DWEYSVWLSN-MAP-specific T cells are not cross-reactive with
autoantigens
We have previously observed that the serum response in this peptide-induced model of SLE includes a variety of Abs with specificities similar to those found in SLE, including anti-histone and
anti-Sm/RNP (18, 21). Theories explaining the polyreactivity that
is typical of the human disease include cross-reactivity of antiforeign and anti-self Abs (24), somatic mutation of the anti-foreign
response to generate autoreactivity (25, 26), and epitope spreading
of the immune response to target self Ags (27–33). We have previously shown that cross-reactivity of the serum Abs accounts for
much of the anti-self response in these mice (18). To determine
whether cross-reactivity at the level of the T cell contributes to the
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FIGURE 5. Serum response of mice immunized with various peptides.
Mice were immunized with the peptides DWEYS-MAP,
DWEYSVWLSN-MAP, DWEYSVWLSN, and (DWEYSVWLSN)3 in
CFA on day 0 and then boosted with IFA on days 7 and 14. Control mice
were immunized with adjuvant alone using the same regimen. ELISA to
assay for the presence of IgG Abs to the immunizing Ag was performed as
described on 1/500 diluted sera. Results are presented as the mean absorbance at 405 nm of five mice in each group. All assays were performed in
duplicate.
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production of autoantibodies, we immunized mice with
DWEYSVWLSN-MAP and pulsed lymph node cells with the immunizing peptide as well as histone and Sm/RNP. The results in
Fig. 4c show that proliferation occurs only in response to the immunizing peptide, indicating that there is no cross-reactivity at the
level of the T cell epitope in the initial T cell response.

Discussion
Many studies have shown that T cells play a central role in disease
manifestations of SLE. Production of autoantibodies by B cells
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FIGURE 7. DWESYVWLSN-MAP requires Ag uptake and processing
to induce T cell proliferation. A, T cells (3 ⫻ 105) purified from lymph
nodes of mice immunized with DWEYSVWLSN-MAP in CFA or with
CFA alone 1 wk earlier were cocultured in triplicate for 72 h with 1 ⫻ 105
fixed DC that had been pulsed with peptide in the presence or the absence
of 20 mM NH4Cl the previous day. Effective fixation was confirmed by
trypan blue staining of DC. Control DC that had been incubated with Ag
in the presence of NH4Cl but not fixed were able to induce T cell proliferation comparable to DCs pulsed with Ag only, confirming that the effects
of NH4Cl are reversible and that the concentration of NH4Cl used is not
toxic to cells. B, T cells (2.5 ⫻ 105) purified from lymph nodes of mice
immunized with DWEYSVWLSN-MAP in CFA or with CFA alone 1 wk
earlier were cocultured in triplicate for 72 h with 1 ⫻ 104 DC that had been
pulsed with peptide at either 4 or 37°C for 3 h the previous day. The lower
temperature had no effect on cell viability as determined by trypan blue
staining and did not cause nonspecific alterations in the Ag-presenting
capabilities of DC, since control DC placed at 4°C for 3 h before Ag
pulsing were just as capable of inducing T cell proliferation as those not
incubated at the lower temperature (p ⫽ 0.08; data not shown). A and B, T
cell proliferation was assayed as described above. Results are expressed as
the mean stimulation index for triplicate determinations of T cells and DC
cultures. Stimulation index is defined as the counts per minute observed in
DC cultured with T cells derived from mice immunized with peptide in
CFA divided by that observed in DC cultured with T cells derived from
mice immunized with CFA alone. Results are representative of three separate experiments, all yielding similar results.

requires T cell help (34) and athymic MRL-lpr and NZB/NZW
mice do not develop SLE (27, 35, 36). In addition, interference
with T cell activation by blocking MHC class II TCR (2, 4),
CD28-B7 (5, 6), or CD40-CD40 ligand interactions in several
mouse models of SLE abrogates disease (7, 8). Although doublenegative as well as CD8⫹ T cells capable of providing the necessary signals for autoantibody production have been isolated from
lupus patients, CD4⫹ cells seem to be the primary cells responsible
for initiating the autoimmune response. They provide the strongest
help to anti-DNA B cells in coculture experiments (37–39), and
anti-CD4 Ab prevents autoantibody production (3). Our studies
indicate that both the peptide and the anti-self response in this
Ag-induced model of SLE are T cell dependent and that the primary T cells responsible for the Ab production are CD4⫹. This is
similar to findings in both human SLE and the spontaneous mouse
models of the disease.
Although the T cell requirement for production of pathogenic
anti-dsDNA Abs is clear, there is much debate regarding the subset
to which they belong. Th1 and Th2 cells differ in their secretion of
cytokines and their effector function (40, 41). Th1 cells secrete
IL-2, IFN-␥, and TNF and are responsible for cell-mediated immunity, whereas Th2 cells secrete IL-4, IL-5, IL-6, IL-10, and
IL-13 and are a driving force for humoral immunity. The two
subsets are able to regulate one another. Th1 cytokines along with
IL-12 favor the development of Th1 cells and down-regulate Th2
cells, while IL-10 and IL-4 down-regulate Th1 responses. Because
cytokines are such powerful modulators of immunity and inflammation, their role in SLE has been studied extensively. Although
SLE is an Ab-mediated systemic disease, the prediction that it is a
Th2-driven autoimmune disease has been questioned. It appears
that both Th1 and Th2 cytokines can play an important role in
disease pathogenesis. IL-2 (42– 46), TNF-␤ (47–52), IL-4 (53–56),
and TGF-␤ (57) have all been implicated in disease pathogenesis,
although the exact roles of these cytokines remain ambiguous, with
elevated levels causing disease remission in some models and exacerbation in other models. Elevated levels of IFN-␥, on the other
hand, have been more consistently associated with SLE (58, 59).
Lupus-prone mice given exogenous IFN-␥ have accelerated disease, while their disease can be delayed by the administration of
anti-IFN-␥ Ab60 or soluble IFN-␥ receptor (60, 61) or by the deletion of either the IFN-␥ gene or its receptor (62, 63). Decreasing
IFN-␥ levels seems to have its beneficial effects through a reduction in the level of MHC II on the surface of APCs (62), reduced
T cell proliferation (64), and reduced production of NO (65). Alterations in IFN-␥ levels have also been associated with differential
processing and presentation of antigenic peptides on class II (66,
67) through the selective regulation of the cathepsins (68, 69).
Consistent with the importance of IFN-␥ in the disease manifestations of SLE is the finding that IL-12 is also elevated in autoimmune mouse models (70, 71). In this study the initial T cell
response is characterized by the production of IFN-␥. The autoantibody response is primarily ␥1, so it is possible that IL-4-producing T cells are recruited to the response over time.
Our results show that the T cell response is I-Ed restricted. It has
been postulated that histones provide the T cell epitope for the
anti-nucleosome anti-DNA response and that I-Ed molecules are
especially able to present such positively charged peptides because
of the extensive negative charge present in the key binding pockets
of this class II molecule (22). It is of interest that the MAP-linked
peptide (DWEYSVWLSN) used to induce anti-dsDNA Abs contains some of the features favorable for an interaction with I-Ed
molecules, such as the aromatic residue tryptophan and the aliphatic residues valine and leucine, yet the peptide is extremely
negatively charged, with an isoelectric point of 2.4. It is tempting
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to speculate that lysines derived from the backbone provide the
necessary positive charge for binding to I-Ed molecules. It has
been shown that the MAP backbone can alter the MHC restriction
of a malaria-derived peptide, possibly by generating new helper
cell epitopes (72). Other studies, however, have shown that MAP
peptides elicit similar T cell proliferation of MAP peptide-primed
T cells as their monomeric counterparts, arguing against the creation of any neo-epitopes by MAP conjugation (73). Rather, it was
postulated that the MAP backbone contributed to the breaking of
B cell tolerance. The results presented in our study favor a role for
the MAP backbone in generating the correct T cell epitope.
While we hypothesize a direct contribution of the MAP backbone to the T cell epitope as a likely explanation for our results,
other possibilities should be considered. We have shown that
DWEYSVWLSN-MAP requires uptake and processing by APC
for presentation to cognate T cells. Therefore, it is also possible
that the MAP backbone allows more effective internalization by
APC, targets the peptide to the correct compartment for processing, or orients the peptide in such a way so as to allow generation
of the correct T cell epitope.
We considered the possibility that cross-reactivity at the level of
the TCR might occur between epitopes derived from
DWEYSVWLSN-MAP and those derived from proteins that are
targeted autoantigens in this model. We, therefore, immunized
mice with DWEYSVWLSN-MAP and looked for T cell proliferation in response to histone and Sm/RNP. We found no crossreactivity at the level of the peptide-specific T cells. These results
make TCR cross-reactivity with nuclear Ags an unlikely mechanism for the initial breakdown in self-tolerance observed in
BALB/c mice following peptide immunization; the autoantibody
response to histone and Sm/RNP is not accompanied by a T cell
proliferative response to these Ags. The possibility remains, however, that epitope spreading may occur later in the response and
account for subsequent progression of the polyreactivity of the
serum response. This observation is consistent with a study by
Goodnow and colleagues (7) demonstrating that autoreactive B
cells are less susceptible to tolerance induction that autoreactive T
cells.
Overall, the data indicate that immunization of wild-type
BALB/c mice with a peptide mimetope of dsDNA replicates the T
cell dependence of SLE. The response is characterized by cells that
produce IFN-␥, at least at the inception of the response. T cell
proliferation and the generation of an anti-foreign and anti-self B
cell response require the presence of both DWEYSVWLSN and
the MAP backbone. The breakdown in self-tolerance does not occur through cross-reactivity at the level of the T cell with peptides
from self Ags. Rather, T cells responding to a foreign Ag and not
cross-reactive with peptides from self-Ag may activate cross-reactive B cells that recognize both foreign and self Ag. While there
has been much focus on autoreactive T cells in SLE, these studies
suggest that SLE may arise through activation of T cells to foreign
Ag and molecular mimicry at the B cell level.
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